# NRX Pharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 10-K/A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:33 ET
- Period: 2024-12-31
- Accession: 0001437749-25-013874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925013874/nrxp20241231_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774925013874/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774925013874/nrxp20241231_10ka.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-013874. Last ingested by Listed: Nov 5, 2026, 19:01 ET. No prices; not investment advice.